1. Home
  2. GRRR vs PRME Comparison

GRRR vs PRME Comparison

Compare GRRR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorilla Technology Group Inc.

GRRR

Gorilla Technology Group Inc.

HOLD

Current Price

$14.50

Market Cap

355.7M

Sector

Technology

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.54

Market Cap

553.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRRR
PRME
Founded
2001
2019
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.7M
553.2M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
GRRR
PRME
Price
$14.50
$3.54
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$7.56
AVG Volume (30 Days)
816.8K
2.5M
Earning Date
06-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
N/A
$4,632,000.00
Revenue This Year
$69.35
$7.06
Revenue Next Year
$85.38
$47.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
55.28
52 Week Low
$9.04
$2.67
52 Week High
$23.49
$6.94

Technical Indicators

Market Signals
Indicator
GRRR
PRME
Relative Strength Index (RSI) 48.93 51.61
Support Level $13.46 $3.14
Resistance Level $16.18 $3.72
Average True Range (ATR) 0.62 0.22
MACD -0.06 -0.03
Stochastic Oscillator 50.65 45.70

Price Performance

Historical Comparison
GRRR
PRME

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments. Its expertise lies in revolutionizing urban operations, enhancing security, and optimizing digital transformation. It delivers pioneering products that integrate AI, deep learning, and edge computing to advance intelligent video surveillance, facial recognition, license plate recognition, post-event analytics, cybersecurity, and network intelligence.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: